Managing Neovascular (Known as "Wet") Age-related Macular Degeneration Over 2 Years Using Different Treatment Schedules of 2 mg Intravitreal Aflibercept Injected in the Eye
Clinical trial NCT02581891 · COMPLETED
Trial details
- NCT number
- NCT02581891
- Sponsor
- Bayer
- Status
- COMPLETED
- Phase
- Phase 4
- Study type
- INTERVENTIONAL
- Start date
- 2015-11-19
- Primary completion
- 2019-04-26
- Enrollment
- 287
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.